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Abstract  
Lumpy skin disease (LSD) is economically important viral disease of cattle mainly in Africa and Middle East. 
Mass vaccination is a better strategy to control this disease in endemic countries. However, there is an increasing 
field report of vaccine failure. Thus, observational study was designed to investigate LSD outbreaks and vaccine 
effectiveness. Different dairy farms were selected on basis of reports of outbreak occurrence. A total of 191 dairy 
cattle from 17 smallholder and 1551 from four big dairy farms were included for assessment. Skin biopsies were 
taken from 31 LSD affected cattle for isolation and molecular characterization. Semi-structured questionnaires 
were administered to farm owners, animal health personnel and farm managers to gather relevant epidemiological 
data. Out of 1742 dairy cattle, 213 (12.2%) showed characteristic clinical signs of LSD and 27 cattle (1.5%) were 
died as the result of the disease. Viruses were isolated from 26 skin samples on Vero cell line and the isolates were 
confirmed to be LSDV using conventional PCR and real-time PCR. The complete sequence of RPO30 gene of the 
isolates showed that all isolates substituted at least one nucleotide in respect to vaccine strains. The vaccine 
effectiveness of annual vaccination was estimated to be 67.1% (95% CI = 57.3 – 74.7) in contrast to vaccination 
during outbreaks. Conversely, the occurrences of outbreak of LSD infection in vaccinated dairy herds are 
suggestive of vaccine failure. Thus, it’s the time to direct efforts towards to the development of new effective 
vaccine. 
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1. INTRODUCTION  
Lumpy skin disease (LSD) is a viral disease of cattle which is characterized by high fever, multiple circumscribed 
firm skin nodules, enlargement of superficial lymph nodes, nasal discharge and lachrymation; but in severity, 
clinical signs are highly variable.  It is caused by Lumpy skin disease virus which is a member of the Capripoxvirus 
genus in the Poxviridae family. The virus is antigenically indistinguishable from other capripox viruses such as 
sheep pox virus (SPPV) and goat pox (GTPV) (Davies and Otema 1981; Woods 1988). LSDV mainly affects cattle 
and the disease is more severe in lactating and pregnant cows (Tuppurainen and Oura 2012).  
Transmission has mostly been associated with blood-feeding insects with frequent feeding habits (Lefèvre and 
Gourreau, 2010; Chihota et al., 2001). Ticks have recently been implicated in the transmission of LSDV 
(Tuppurainen et al., 2011). The morbidity and mortality rates of LSD vary considerably, depending on host 
susceptibility and the abundance of insect vectors involved in transmission. The morbidity rates are generally 
between 1% and 20%, but in few outbreak reports the morbidity rates exceeded 50%. On the other hand, mortality 
of 10 to 40% and even higher have been reported on occasion but the lower range of 1 to 5% is more usual (Babiuk 
et al., 2008).   
Lumpy skin disease was first observed in 1929 in northern Rhodesia (currently Zambia) and rapidly spread 
north and south of Africa (Tuppurainen and Oura 2012). The disease was then reported in out of Africa in different 
countries in the Middle East in late 1980s (Mohamed et al., 2014). It now appears to be spreading to new territories 
such as turkey and Iraq and threatens the entire European countries (EMPRES, 2013). LSD was first observed in 
Ethiopia in 1983 in the northwestern part of the country (Mebratu et al., 1984). It has now spread to almost all 
regions and agro-ecological zones and became endemic. Epidemic reoccurs after an interval of 5-6 years cycle in 
cattle population (Gari, 2011). The disease causes high economic losses through decreased milk production, 
emaciation and poor growth in infected animals, permanent damage to hides, abortion, temporary or permanent 
infertility, and sometimes death (Tuppurainen and Oura, 2012; Babiuk et al., 2008; Chihota et al., 2003).  
Moreover, it adversely affects the trade of livestock and livestock products. LSD is categorized by the World 
Organization for animal Health (OIE) as notifiable diseases due to their potential for rapid spread and substantial 
economic impact. On the other hand, the livelihood of more than 80% of population of Ethiopia is dependent on 
livestock. Therefore, LSD is one of the most economically important livestock diseases in the country. 
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Vaccination is the effective method to control the disease in endemic countries like Ethiopia. The attenuated 
Kenyan sheep-and-goat pox vaccine strain KS-1 has been used to protect cattle against LSD in the country because 
of its advantage of conferring cross-protection to LSD (OIE, 2012).  In contrary, field reports of LSD outbreak in 
vaccinated animals has been increasing during past years (Ayelet et al., 2014; Gelaye et al., 2015; Abutarbush, 
2013; Brenner et al., 2009). Similar phenomenon has also reported from other countries (Abutarbush, 2013; 
Brenner et al., 2009). Furthermore, similar reports also came from different smallholder and big dairy farms 
following 2014/15 LSD outbreak eruption in Ethiopia and these demanded investigation of the situation.  
As the result, the vaccine production companies and scholars are motivated to rule out the cause behind the 
current LSD vaccination failure. There is also a knowledge gap in the country to fully understand the existing 
incomplete protection of the vaccine. In addition, there are few studies on the type of the virus circulating in 
Ethiopia.   
Therefore, the objectives of this study were: 
 To isolate and characterize virulent field isolates of LSDV circulating in the area;  
 To assess the current LSD vaccine effectiveness in the context of the existing vaccination strategy 
 To investigate LSD outbreak in dairy cattle in the central parts of Ethiopia 
 
2. MATERIALS AND METHODS 
2.1. Study Area  
Outbreak investigation was undertaken from September 2014 to January 2015 in the central parts of Ethiopia. Five 
towns from three Zones of Oromia Regional State; naming East Shoa (Bishoftu), North Shoa (Selale), West Shoa 
(Ambo, Holeta and Ginchi) and Akaki-Kaliti sub-city of Addis Ababa were purposively selected for the study 
based on LSD outbreak report. The altitude of the study areas ranges from 2391 m at Holeta town and 1,500-2,200 
m at Bishoftu town above sea level. The areas exhibit a bimodal pattern of rainfall, with the highest rainfall 
concentration occurs from June to September and the short rainfall from March to April. The annual average 
rainfall of these areas is estimated from 1,150 and 2,200 mm and the annual mean daily temperature varies from 
12.9 0C to 28.6 0C with moderate seasonal variation (NMSA, 2005).  
 
2.2. Study Animals and Farms 
All animals in the study were crossbreds with different exotic blood level and were kept for dairy and research 
purposes. Since the dairy farms were intended for milk production, study animals were largely cows and heifers. 
The farms included in the study were categorized as smallholder and big dairy farms based on herd size and 
management system. 17 smallholder dairy farms were included in this study. The smallholder dairy farms contain 
2 to 30 dairy cattle and managed under intensive system and were usually known as urban dairy farms.  
Four big dairy farms were also included in this study. These were   Ethiopian Dairy and Meat Industry 
Development Institute (EDMIDI), Bishoftu;  Ethiopian Institute of Agricultural Research (H-EIAR), Holeta; 
Ethiopian Institute of Agricultural Research (B-EIAR), Bishoftu and Selale Dairy Development Farms (SDDF).  
The big dairy farms hold more than 100 cattle each and provided with concentrate feeds and allowed to graze on 
farms owned pasture. However, SDDF uses concentrate feed and communal pasture for grazing. The big dairy 
farms separately managed young and adult animals. Big farms had their own animal health personnel to handle 
their animal health issues such as regular monitoring, treating and vaccinating animals. However, the smallholder 
dairy farms seek advice from veterinarians when their animals encounter serious health problem.  
 
2.3. Study Design  
The study areas were selected purposively based on reports of LSD outbreaks came to NVI. Three smallholder 
dairy farms from Akaki, seven from Bishoftu, two from Ambo and five from Ginchi were included to assess field 
LSD vaccine effectiveness. A total of 191 and 1551 dairy cattle were included in the study from 17 smallholder 
dairy farms and four big dairy farms respectively.  
In addition, semi-structured questionnaires were administered to 25 purposively selected farm owners, 
veterinarians, animal health professionals and production managers to generate information. Information on 
vaccination history; clinical signs, age, sex, and breed of animals, management system, morbidity, and mortality 
was gathered. 
  
2.4. Sample Collection  
During visit, visual inspection was made to observe health status of the entire animals in the farms and detailed 
physical examination was done for sick animals suspected of having LSD. A total of 31 skin nodules were taken 
from representative sick animals for virus isolation and antigen detection according to the procedures of OIE 
(2010). The samples were taken aseptically by cleaning the area and removing the hairs with the help of sterile 
scalpel blade. Tissue samples were placed in the sterilized universal bottle and transported to NVI virology 
laboratory within 4 to 8 hours of collection within icebox and kept at -20 0C until processed. 
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2.5. Laboratory Techniques  
2.5.1. Sample Processing 
The skin biopsy samples were thawed at room temperature and washed three times using sterile phosphate buffer 
saline (PBS) at a pH of 7.2 in Bio-safety cabinet Class II. The biopsy tissue was minced using sterile scissors and 
forceps. About 1 gm of the sample was ground using sterile pestle and mortar by adding 9 ml of the sterile PBS at 
a pH of 7.2 containing 0.1% gentamycin. The tissue suspension was centrifuged at 1,500 rpm for 15 min. The 
supernatant was collected, filtered through 0.45 m pore size (Millipore, USA), labeled and preserved at - 20 0C 
until use.  
2.5.2. Isolation and identification of the virus 
The field isolated poxvirus was inoculated on Vero cell lines according to the method of Balinsky et al. (2008) to 
ascertain the presence of infectious virus. The Vero cell line was propagated in Glasgow Eagle minimal essential 
medium (GMEM) supplemented with 10% calf serum. Vero cell line was grown in 25 cm2 tissue culture flask and 
was incubated with 5% CO2 at 37oC until the cells became confluent monolayer. The tissue culture medium was 
then removed in aseptic conditions and the monolayer washed three times using sterile warm PBS pH of 7.2 in 
Bio-safety cabinet level II. One ml of tissue homogenate was inoculated onto the confluent monolayer and 
incubated at 37 0C and allowed to absorb for 1 hour. Then after covered the monolayer with 10 ml of GMEM, 
containing antibiotics and 2% fetal calf serum into the flask and placed into incubator.  All the flasks, including 
the control flasks, were incubated at 37°C in a humidified incubator with 5% CO2. The medium was changed 
every 48 hours. Cells were monitored daily using an inverted microscope for evidence of virus induced cytopathic 
effects (CPEs) for 7- 14 days post-inoculation. Three more blind passages were carried out for samples that were 
initially CPE. Infected cells developed a characteristic CPE consisting of retraction of the cell membrane from 
surrounding cells; eventually rounding and aggregation of cells were observed. When 80% CPE was observed, 
Virus inoculated flasks were harvested and frozen overnight at –20°C. The harvested cell culture was thawed twice 
at room temperature to release the virus particles. Finally, virus suspensions were stored at -20°C until processed 
for viral DNA detection.  
2.5.3. DNA Extraction  
DNA extraction was performed using DNeasy Blood and tissue kit (Qiagen, Rocm and Haas Company, USA) 
according to the procedures of the manufacturer. DNA was extracted from 26 specimens; 180 µl crude virus in 
culture supernatant from the LSDV infected cells were pipette in to 2 ml of micro centrifuge tube, clarified by 
centrifugation at 8,000 rpm for 5 min. 200 µl of AL buffer (lysis buffer) was added in to the centrifuged virus 
suspension and mixed by vortexing and incubated at 56 0c for 10 min. 200 µl of ethanol (100%) was added and 
mixed thoroughly with the help of vortex mixer. The mixture was transferred in to DNeasy minispin column in 
2ml collection tube and centrifuged at 8,000 rpm for 5 min. The spin column was transferred in to a new 2 ml 
collection tube and 500 µl of AW1 centrifuged at 8,000 rpm for 1 min. Then, the collection tube was discarded and 
the min spin column placed in a new 2 ml collection tube and 500 µl of AW2 was added and centrifuged for 3 min 
at 14,000 rpm, min spin column transferred carefully in to a new 2 ml of micro centrifuge tube and 200 µl of 
elution buffer (AE buffer) added and incubated for 1 min at room temperature centrifuged for 1 min at 8,000 rpm.  
2.5.4. Polymerase Chain Reaction (PCR) 
A polymerase chain reaction (PCR) was carried out to detect the virus using Capripoxvirus-specific primer: 
Forward and reverse had the sequences (SpGpRNAPol-F) 5’ TCTATGTCTTGATATGTGGTGGATAG-3’ and 
(SpGpRNAPol-R) 5’ AGTGATTAGGTGGTGTATTATTTTCC-3’, respectively. DNA amplification was carried 
out in a final volume of 50µl of 10X PCR buffer, 1.5 µl of MgCl2 (50Mm), 1 µl of dNTP( 10Mm), 1µl of forward 
primer, 1µl of reverse primer, 1 µl of DNA template, 0.5 1µl of Taq DNA polymerase and 39 µl of nuclease free 
water. Finally the mix was incubated in a thermal cycler: first cycle: All PCR experiments performed in a PTC-
100 thermal cycler (MJ-Research, Inc., Waltham, Massachusetts, USA) using the following amplification program:  
initial denaturation at 95oC for 1 min; 40 cycles of denaturation  at 95oC for 30 s, annealing at 55oC for 30 s and 
elongation at 72oC for 1 min. An additional elongation step was performed at 72oC for 5 min and the PCR products 
were stored at 4°C until analysis. 
2.5.5. Agarose gel electrophoresis 
The isolated DNA from cell culture was analyzed by agarose gel electrophoresis as described by Mangana-
Vougiouka et al. (1999) with some modification to confirm the presence of DNA. Amplified products were 
analyzed using a gen ruler TM 100bp  DNA ladder (Fermentes, Germany) as a molecular marker on 3% agarose 
gels prepared in Tris/Acetate/EDTA (TAE) buffer and 10mg/ml ETDM- bromide stain, then 20µl of PCR product 
was mixed with 4 µl loading buffer and loaded to wells in previously prepared gel and run at 100 volt for about 
60 minutes in parallel with DNA molecular weight marker in electrophoresis apparatus until the DNA samples 
have migrated a sufficient distance through the gel. DNA bands were visualized using UV transilluminator at a 
wave length of 590 nm, and positive results were confirmed according to the size of the bands formed on agarose 
gel. The PCR results were considered positive for LSDV and GTPV DNA when a 172 bp and SPPV 151 bp product 
were observed.  
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2.5.6. Real-time PCR 
The real-time PCR was executed at Molecular Biology Laboratory, NVI. Each sample was tested in duplicate and 
every PCR run included no-template and positive GTPV, LSDV and SPPV controls. 
5’GGTGTAGTACGTATAAGATTATCGTATATA-3’ as forward primer and 
5’AATTTCTTTCTCTGTTCCATTTG-3’ as reverse primer were used for Real-time PCR analysis.  
The PCR was set up in a 20 µL reaction volume. A total of 1430 µl of the master mix was prepared to 26 samples. 
17 µl of the master mix was dispensed into each micro-well of Low Profile Hard-Shell H 96-well PCR plate (Bio-
Rad). The master mix in each well was composed of 4.84 µl of RNAase free water, 2 µl of forward  primer 
(CHFRsb), 0.16 µL of reverse primer (CHFR1), and 10 µL of 1x SsoFast Eva Green Super mix.  3 µL of sample 
extracted DNA; no-template (RNAase free water); and positive GTPV, LSDV and SPPV controls was added in 
duplicate fashion and sealed. PCR was performed in a CFX96TM real-time PCR detection system with an initial 
denaturation step at 95 0C for 3 minutes, followed by 45 cycles of 95 0C for 15 seconds and 58 0C for 80 second 
using a Low Profile Hard-Shell H 96-well PCR plate (Bio-Rad). The product was then denatured at 95 0C (held 
for 1 minute), cooled to 40 0C (held for 1 minute), and heated continuously at 0.5 0C/10 seconds with fluorescence 
acquisition from 40 0C to 85 0C. The melting temperatures were analyzed using the CFXTM Manager Software 
Version 2.0 (Bio-Rad) and the correspondent curves were displayed as negative first-derivative plots of 
fluorescence with respect to temperature. High-Resolution Melting (HRM) analysis, a post-PCR melting analysis 
method used to identify variations in nucleic acid sequences, was also used to plot the melting profile of the three 
genotypes using the Precision Melt Analysis TM Software (Bio-Rad). Normalized melt curves and difference in 
curves were acquired by selecting pre-and post-melt regions for amplicons separately (Lamien et al., 2011b). 
2.5.7. RPO30 gene sequencing   
The RPO30 gene sequence was done for only seven PCR positives representative samples in the study areas. The 
DNA extracts were sent to Vienna, Austria, for gene sequencing. The PCR was also conducted to amplify the 
DNAs from the extracts. PCR products were also checked using electrophoresis on a 1.5% agarose gel for 1 h at 
100 V. The positive DNA products were purified using Wizard SV Gel and PCR clean-up system kit (Promega) 
and sequenced commercially by LGC Genomics (Germany).  
 
2.6. Data Analysis 
The data obtained from all investigations were coded and stored in Excel spread sheet 2007 and thoroughly 
screened before subjected to statistical analysis. Statistical analysis was applied using SPSS statistical software 
version 19.0. Morbidity and mortality were estimated in accordance with vaccination history, farm types, and age 
categories (in big dairy farms). Mean and Confidence Interval (CI) were also used to describe morbidity and 
mortality across different variables. The effectiveness of the Current LSD vaccine was analyzed in the existing 
vaccination strategies. Field vaccine effectiveness was assessed by the percentage reduction in risk of having LSD 
among regularly vaccinated dairy cattle compared to dairy cattle vaccinated during outbreaks. The formula used 
for calculating vaccine effectiveness (VE) in this study was VE = [(RIV – RRV)/RIV] * 100%, where RIV is risk 
of irregular vaccination (risk of having LSD in dairy cattle vaccinated during the onset of outbreak and RRV is 
relative risk of vaccinated group before outbreak onset. Chi-square (χ2) was employed to test the presence of 
association among different categorized variables. In all the analyses, confidence levels at 95% were calculated, 
and a P≤0.05 was used for statistical significance level (Moulton et al., 1995). 
For genomic analysis, the sequence data were edited and fragments were assembled using Vector NTI 
Advance™ 11.5 software (Invitrogen, Carlsbad, CA, USA).  Phylogenetic tree analysis was included 35 
capripoxviruses based on nucleotide sequences of RPO30 gene complete sequence (606bp). LSDV field isolates, 
attenuated vaccine strain (KS-1 and Gorgon) and reference sequences retrieved from the Genbank database were 
considered in the analysis. The Neighbor-Joining method with the maximum composite likelihood nucleotide 
substitution with the pairwise deletion option was computed using the Kimura 2-parameter method of MEGA6 
software (Tamura, 2013). The percentages of bootstrap scores above 50% (out of 1000 replicates) are shown next 
to the branches.  
 
3. RESULTS 
3.1. Observed Clinical Signs  
The common clinical signs observed in our study were fever, circumscribed nodules on the skin with different 
sizes, necrotic nodules and deep scab formation, edematous swelling of one or two legs, enlargement of superficial 
lymph nodes and decrease in body weight (Fig 1). Lameness and superficial lymph node enlargement were very 
prominent. The nodules on the limbs gradually burst and left necrotic wounds that were frequently seen to be 
complicated with secondary infection (Fig.2). Dysentery and recombency were also seen.  
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) DOI: 10.7176/JBAH 
Vol.9, No.11, 2019 
 
5 
 
Figure 1: Characteristic of LSD with generalized circumscribed skin nodules covering the entire body 
 
 
Figure 2: An inflammatory swelling of the hind leg following complicated wound. 
 
3.2. Virus Isolation  
Out of the 31 skin biopsies, characteristic poxvirus CPE was observed in infected Vero cells with 26 samples 
within ten days of post- inoculation or after one or two blind passages while the virus was not isolated from the 
remaining five samples. None of the negative control cultures showed any CPE after two or three blind passages. 
 
Figure 3: Photo of Vero cell: a) CPE positive on Vero cell after seven days post inoculation; b) control of cell 
culture 
 
3.3. Polymerase Chain Reaction  
The DNAs of 26 isolates on Vero cell line were amplified using capripoxvirus-specific primers indicated in section 
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3.5.4. The amplicon size of PCR product had molecular weight of 172 bp (Fig.7), the expected amplicon size for 
the LSDV genomic region targeted. The resulting PCR products of GTPV/LSDV differed in length by 21 
nucleotides produced from SPPV genomes. After electrophoresis migration of the PCR products on a 3% high-
resolution agarose gel, all amplicons from the SPPV group were shorter (151 bp) and easily distinguishable, 
relative to the GTPV/LSDV amplicons 172 bp (Fig. 7). 
 
Figure 4: PCR based detection of LSDV in samples taken from skin nodules of infected animals. 
Lanes M: DNA ladder; lane N: Negative Control without template; Lanes 1, 2 and 3 represent positive samples 
from Bishoftu; Lanes 4 and 5 represent positive samples from Holeta; Lanes 6 and 7 represent positive sample 
from Ginchi; Lane 8 and 9 is a positive sample from Selale; Lane 10 is a positive sample from Akaki; P1- Positive 
control for LSD and Goat pox- (size 172bp); P2- Positive control for Sheep pox- (size 151bp). 
 
3.4. Real-time PCR  
The DNA extracts forming 172 bands on agarose gel was again subjected to real-time PCR and LSDV 
differentiated from GTPV. The peak melting curve of the real time revealed that all 26 virus isolates were 
characterized  as LSDV since their snapback of  melting peaks were at 51 0C while the second peaks were at 73.50C 
(Fig 8 ). Known CaPV positive samples were tasted for comparison. Real-time PCR assay detected differences in 
the melting point temperatures for SPPV, GTPV and LSDV after fluorescence melting curve analysis from each 
other (Fig 9).    
 
Figure 5: Differences in the melting curve for field isolates of LSDVs 
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Figure 6: Differences in the melting curve for known positive isolates of CaPVs for comparison. 
The RPO30 genes sequence analysis of the current Ethiopian field isolates and the previous LSDV isolates 
showed that substitution of some nucleotides (1-5) with respect to the current NVI vaccine strain (KS-1). 
 
Figure 7: Multiple nucleotide sequence alignment of RPO30 gene of present and previous Ethiopian LSDV 
field isolates, NVI vaccine strain (KS-1), Kenyan SGP O-240 and Ethiopian field GTPV. Sequence analysis of the 
Ethiopian field LSDV isolates showed substitution of at least one nucleotide as compared to the vaccine strain 
(KS-1). 
The 30 KDa DNA-dependent RNA polymerase subunit (RPO30) genes (Lamien et al., 2011a) of 
capripoxvirus were analyzed in order to characterize and compare local isolates and the local vaccine strain. Based 
on multiple sequence alignment of the present isolates’ RPO30 gene complete sequences of 606 bp with KS-1 
vaccine, all the present isolates, C nucleotide  substituted by T (at nucleotide position 292) while Ambo, Ginchi, 
Holeta, Quarit and Selale isolates differed by additional one nucleotide substitution (at nucleotide position 41, C 
substituted by A) from KS-1 vaccine strain. These isolates were similar to previous isolate from East Shoa Zone 
of Oromia Regional State, Ethiopia.  
 
3.5. Phylogenetic Analysis 
Finally, phylogenetic reconstructions were performed to determine the genetic relationship among Ethiopian 
isolates as well as other CaPV isolates. In general, phylogenetic analysis indicates that all representative isolates 
(n=7) were identical to LSDV and related to SPPV and GTPV. Phylogenic tree analysis categorized the present 
field virulent isolates into two clusters. The isolates obtained from Bishoftu and Kaliti were found to be 99% 
similar to the previously isolated LSDV strains from Adama, Andassa, Bishoftu, Modjo and Wenji. These isolates 
were also closely related to the isolates of Burkina Faso, Egypt and Niger. However, the isolates from Ambo, 
Ginchi, Holeta, Quarit (West Gojam) and Selale separately formed other cluster which was closely analogous to 
Sudan isolates (Fig 11). 
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Figure 8: Phylogenetic tree analysis of 35 capripoxviruses based on nucleotide sequences of RPO30 gene 
complete sequence (606bp). The current isolates are marked with black square box. 
 
3.6. Vaccination Strategy against LSD 
The questionnaire survey revealed that, vaccination against LSD is usually done during outbreak eruptions in the 
areas. All visited smallholder dairy farm owners responded that they did not have regular vaccination program 
against the disease. Out of 17 smallholder dairy farms, three owners of the Akaki-Kaliti sub-city of Addis Ababa 
and three owners of Bishoftu town gave the vaccine after they had already observed disease in their farms. 
However, the remaining 11 owners (64.7%) vaccinated their animals prior to the occurrence of the first case in 
their farms. In such vaccination strategy, drastic increments of the number of new cases were a big concern for the 
farm owners and animal health workers. In contrary, big dairy farms do have their own regular vaccination 
schedule and vaccinate their animal annually against LSD before the beginning of the main rainy season. Despite 
their efforts, LSD outbreak was seen in assessed big dairy farms after six to ten months of the last vaccination 
(Annex 3). Isolation of infected animals and broad spectrum treatment such as 20% Oxy tetracycline and pen-
strips were the intervention measures taken by all big dairy farms. 
 
3.7. Outbreak Investigation and LSD Vaccine Effectiveness    
Out of 1742 dairy cattle observed, 213 animals (12.2%) were developed LSD clinical signs with physical 
examination. Low morbidity rate of 10% (95% CI = 0.08 – 0.11) was recorded in regularly (annually) vaccinated 
cattle, whereas high morbidity of 30.4% (95% CI = 0.24 – 0.37) was found in dairy cattle vaccinated during 
outbreaks. The 95% CIs of morbidity rates elicits that regularly vaccinated dairy cattle and dairy cattle vaccinated 
during outbreak were statically different.  LSD vaccination strategy was also significantly associated (P<0.05, χ2= 
65.768) with the morbidity rate (Table 2). 
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Table 1: Morbidity of LSD in dairy cattle having regular vaccination and vaccination during outbreak 
Regular vaccination  Total animals No. of sick animals Morbidity  95%  CI χ2 P- value 
Present   1551 155 0.100 0.08 – 0.11 65.768 0.000 
Absent   191 58 0.304 0.24 – 0.37   
Total  1742 213 0.122 0.11 – 0.14   
On the other hand, only 27 dairy cattle (1.5%) were dead from all visited dairy animals. Mortality rate of 0.6% 
(95% CI = 0.00 – 0.01) in regularly vaccinated dairy cattle was lower than mortality of dairy cattle vaccinated 
during outbreak 9.4% (95% CI = 0.05 – 0.14). The 95% CIs of the groups illustrate absence of statistical difference 
between the two dairy cattle populations. Statistical significant difference (χ2 = 87.165, P< 0.05) was revealed 
between LSD mortality rate and vaccination history.  
Table 2: Mortality of LSD in dairy cattle with different vaccination history 
Regular vaccination Total animals No. of dead animals Mortality 95%  CI χ2 P- value 
Present     1551 9 0.006 0.00 – 0.01 87.165 0.000 
Absent  191 18 0.094 0.05 – 0.14   
Total  1742 27 0.015 0.01 – 0.02   
In the context of the existing vaccination strategy, the relative risk of having LSD in annually vaccinated 
dairy cattle was 32.9% (95% CI = 0.253 – 0.427) lower than in dairy cattle vaccinated during outbreaks. Therefore, 
the effectiveness of regular annually vaccination against LSD was estimated to be 67.1% (95% CI = 57.3% - 74.7%) 
as compared to vaccination during outbreak occurrences. The relative risk of death in regularly vaccinated dairy 
cattle was calculated to be 6.2% (95% CI = 0.028 – 0.135) and thus, 93.8% mortality reduction was observed in 
regularly vaccinated dairy cattle. 
 
Figure 9: Morbidity and mortality rates in dairy cattle with different vaccination strategy 
Morbidity was done in three big dairy farms (B-EIAR not considered) and the study included a total of 1436 
cattle. Affected animals in regular annual vaccinating farms were divided into two age groups: young (<2 years) 
and adult (>2 years). There was higher morbidity of 31% (95% CI = 0.26 – 0.36) observed in young cattle group 
than 3 %( 95% CI = 0.02 – 0.04) morbidity rate in the adults. This difference was highly significant since the two 
groups of 95% CIs didn’t overlapped. The age specific morbidity was statistically significant association (χ2 = 
2.434, P< 0.05) to their age group in big dairy cattle. 
Table 3: Morbidity of LSD in regularly vaccinated three big dairy cattle by age category  
Age category  Total animals No. of sick animals Morbidity 95%  CI χ2 P-value 
< 2 years 389 121 0.31 0.26 – 0.36 2.434 0.000 
> 2 years 1047 29 0.03 0.24 – 0.04   
Total  1436 150 0.10 0.09--0.12   
 
4. DISCUSSION  
The findings of clinical signs, virus isolation, and PCR diagnosis confirmed that the outbreak was caused by LSDV. 
Clinical signs observed on LSD infected dairy cattle were fever, circumscribed skin nodules, enlargement of lymph 
nodes, inappetence, lacrymation, salivation, reduction of milk production and death. These signs have been 
documented as characteristic clinical features of LSD (OIE, 2012; Radostits et al., 2007; Carn and Kitching, 1995). 
Edematous swelling of legs and lameness were very common signs. Similar situation was recorded during Oman 
LSD outbreak (Mohamed et al., 2014). The complications such as dysentery and recombency were also reported 
from Egypt and Oman (Mohamed et al., 2014). Out of 31skin biopsies, characteristic of Capripoxvirus CPE was 
observed only on 26 skin samples following post-inoculation on Vero cell line. Whereas, virus isolates could not 
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) DOI: 10.7176/JBAH 
Vol.9, No.11, 2019 
 
10 
be identified from the remaining five skin samples. This might show the absence of infectious virus particles from 
scarified skin tissue. All isolates were identified as LSDV after sequential diagnosis using convention PCR and 
real-time PCR. 
Furthermore, molecular phylogenetic analysis confirmed the identifications made using real-time PCR. 
Multiple alignment analysis of complete sequences of RPO30 gene 606 bp of present field virulent isolates, KS-1 
vaccine strain and past isolates revealed that there was high homology percentage ( 99%) of the nucleotide 
sequence among the current Bishoftu and Kaliti isolates and previous isolates from Adama, Andassa, Bishoftu, 
Modjo and Wenji. This result rules out that these virulent LSDV field strains are still circulating in the eastern 
central part of the country. Other present isolates (Ambo, Ginchi, Holeta, Quarit and Selale) were slightly different 
from the former isolates by replacing A nucleotide by C (nucleotide position 41) and formed a separate cluster 
which is related to Sudan strain. Interestingly, all the current and previous field isolates have substituted T 
nucleotide by C (nucleotide position 292) in contrast to vaccine strains. Even though these findings might not show 
any change in amino acid substitutions, Gelaye et al. (2015) unveiled 12 nucleotides deletion from the previous 
isolates of GPCR genes as compared to KS-1 vaccine strain.  
Attenuated KS-1 vaccine strain has been produced by NVI and distributed across the country to control LSD. 
The vaccine is usually used for stopping ongoing outbreaks by mass vaccination campaign, except in big dairy 
farms for annual vaccination. This vaccine strain was thought to be SPPV in the past years, but it has confirmed 
to be LSDV in recent years (Gelaye et al., 2015; Tuppurainen et al., 2014). The Yugoslavian RM 65 sheep-pox 
virus strain, the Romanian sheep-pox virus strain and the South African Onderstepoort LSDV strain are 
recommended vaccines to control LSD (Kitching, 2003; Carn and Kitching, 1995, OIE, 2012). All these strains of 
capripoxvirus were predicted that they could protect cattle against LSDV as they share a major neutralizing epitope. 
Moreover, it is claimed that vaccinated animals will develop protective immunity from 10 to 21 days post-
vaccination, and then required an annual booster dose (OIE, 2010).  
In contrary, outbreaks were appeared in vaccinated herds after five to ten months of the last vaccination date 
and two weeks to two months of post vaccination in smallholder dairy farms. The incomplete protection following 
vaccination discouraged dairy farmers to vaccinate their animals, consequently rendering more dairy cattle at risk. 
Abutarbush (2014) has also reported the occurrence of outbreak after 5 to 20 days post vaccination. Post-
vaccination LSD outbreak occurrence may be indicative of incomplete protection. This finding is in support of 
incomplete protection of KS-1 vaccine strains against circulating virulent field strains in Ethiopia (Ayelet et al., 
2014) and in Oman (Mohamed et al., 2014). Such situation of other vaccine strains has been reported in Egypt and 
Israel (Brenner et al., 2009), and Jordan (Abutarbush, 2014). Furthermore, there was increasing new cases 
following mass vaccination during outbreak eruptions. This might be result of vaccination of incubatory cattle 
accompanied by unhygienic vaccination. 
In the present study, morbidity (12.2%) and mortality (1.5%) were recorded in the dairy cattle regardless of 
vaccination history. These findings are in agreement with 13.5 % of morbidity rate (Brenner et al., 2009) and low 
mortality rates 1.26% (Gari et al., 2011). However, several literatures reported that the morbidity and mortality 
rates of LSD vary. The morbidity rate of the disease ranges from 5 to 100% (Woods, 1988).  While occasional 
mortality rates from 10 to 40% have been reported (EMPRES, 2013), but the rate of 1 to 5% is usually observed 
(Woods, 1988). These values vary with geography, climate, management conditions, and immune status of the 
animals, breed and strain of virus involved (Tuppurainen and Oura, 2012).  
In the present study, the morbidity in dairy cattle vaccinated during outbreak was more than three times with 
that of annually vaccinated dairy cattle. The morbidity in annually vaccinated herds (10%) is in agreement with 
morbidity rate of 9.5% (Abutarbush, 2014) and 11.1% (Brenner et al., 2009) in vaccinated cattle population. A 
morbidity rate of 30.4% in dairy farms vaccinated after outbreak eruption is in comparable with the report of 22.5% 
morbidity in cattle vaccinated after infection (Abutarbush, 2014).  
On the other hand, the present mortality in dairy cattle vaccinated during outbreaks was recorded to be more 
than 15 times higher than those of dairy cattle annually vaccinated. The mortality of 0.6% in regularly vaccinated 
dairy cattle is relatively lower than 2.4% morality observed vaccinated Jordanian cattle (Abutarbush, 2014). Two 
third of dead dairy cattle as result of the LSD outbreak were reported in lactating and pregnant cows. Stressful 
physiological status of the animals makes them prone to the disease.  The average price of a cow during study 
period was estimated to 35,000 Eth birr while 25,000 Eth Birr for a heifer. Thus, although economic losses mostly 
from morbidity (Woods, 1988), a mortality of 9.4% causes a heaviest economical burden on poor smallholder 
dairy farm owners whose livelihood mainly relies on. 
Attempt was also made to compare KS-1 vaccine effectiveness between the existing vaccination strategies. 
In the present study, the relative risk of having LSD infection in regularly vaccinated dairy cattle was 0.329 times 
lowering than the risk of vaccinated during outbreaks. Thus, the vaccine effectiveness using annual vaccination 
was estimated to be 67.1% as compared to vaccination when outbreak occurrences. On the other hand, the 
implementation of annual vaccination in smallholder dairy farms could also reduce their mortality by 93.8%. Most 
of cattle used for dairy purpose were cross bred with Holstein-Friesian breed which are relatively susceptible to 
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LSD infection (Babiuk et al., 2008). Therefore, annual vaccination using KS-1 vaccine is still the existing 
alternative to reduce the impact of the disease in susceptible diary animals. However, the observation of a 
morbidity of 10% in annually vaccinated dairy cattle is frustrating and urges the development of better, effective 
and safe LSD vaccine. 
In regularly vaccinated dairy cattle, morbidity of young animals were ten times higher than adult cattle. This 
age specific susceptibility is in accordance to the findings of Ayelet et al. (2014). Calves less than six months of 
age were not received the vaccine during vaccination and the number of calves exhausting their maternal immunity 
increases as the last vaccination date is advancing. Conversely, adult herd could build strong immunity against 
infection due to repeated vaccination or natural infection. Thus, herd immunity variation possibly explains 
morbidity difference between the two age categories in the present study. 
 
5. CONCLUSIONS AND RECOMMENDATIONS 
The present outbreak investigated in dairy cattle was caused by LSDV. Smallholder dairy farms were highly 
affected by the outbreak as compared to big dairy farms. The presence of regular vaccination in big dairy farms 
was significantly associated to the observed relatively low morbidity and mortality rates. Despite vaccination 
during outbreak eruption, increasing mortality of the outbreak causes economic burden to poor smallholder dairy 
farm owners whose livelihood is heavily relied on dairy farming. It is undeniable that LSD outbreak was occurred 
in vaccinated dairy cattle. Such phenomenon is an indicative of KS-1 vaccine incomplete protection. The current 
study shows that there is nucleotide missing among the circulating isolates of LSDV in relation to the vaccine 
strain (KS-1). Recently this event could be another challenge for the effective control of the LSD. This poor 
protection of the vaccine can discourage the dairy farmers from using vaccination to protect their herds, thereby 
putting more animals at risk. However, annual vaccination against LSD using this vaccine provides a better 
protection to dairy cattle with respect to dairy cattle vaccinated during outbreak eruptions. Younger animals were 
more susceptible age group in regular vaccinated dairy cattle herds. Based on the above conclusion the following 
recommendations are forwarded. 
 Regular annual vaccination should be implemented in every dairy farm since it is still the only alternative 
for LSD susceptible animals in endemic countries; 
 Efforts need to be directed for the development of an effective vaccine, thereby contributing to better 
control of LSD in the future; 
 Detailed molecular studies should be done to discover the variation of circulating virulent field strains, 
thus developing new vaccines by targeting genes specifically involved in virulence and host immune 
system modulation. 
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